Roche pathologist resources

Learn. Collaborate. Impact patient care.

Resources to support pathologists

The Pathology Lab Global Medical Affairs team is the medical and scientific face of Roche Tissue Diagnostics, collaborating with the broader medical, diagnostic, biotech and patient community. We connect with key thought leaders and stakeholders to generate real world data, provide pragmatic knowledge and education surrounding our high medical value assays and tirelessly work to provide solutions that enable patients access to our diagnostic solutions around the globe.

Pathologist eLearning Portal

About our anatomic pathology online courses

With new emerging biomarkers and new technologies, the practice of pathology is growing and changing daily.  We are committed to providing pathologists with up-to-date information, education and training that will advance your knowledge and elevate your confidence in results. This portal provides the tools you need to explore and understand the newest horizons of pathology, including companion diagnostics, immunotherapy, and biomarker and disease state information.  Below, find access to educational modules, cutting-edge research articles, and more. 

Our dedicated team of in-house pathologists has developed a variety of educational modules, including videos and interactive courses, to aid in the interpretation of our assays. Access these modules, along with cutting-edge research articles and more, below.

Roche Healthcare Consulting

Featured courses: high medical value assays

VENTANA ALK (D5F3) Assay in non-small cell lung cancer (NSCLC)

A comprehensive interactive training course for the only CE marked Companion Diagnostics ALK IHC binary assay for NSCLC. The course is designed for pathologists and other professional users to provide background, science and interpretation of the VENTANA ALK (D5F3) Rabbit Monoclonal Primary Antibody (VENTANA ALK (D5F3) Assay) for use in the evaluation of NSCLC.

Over the sequential four modules, the user will learn how to assess the staining and interpretation of the VENTANA ALK (D5F3) Assay and concludes with a proficiency test. A certificate is offered to those who successfully complete the course.

 

Course completion time: 2-3 hours

 

Modules

 

  1. Introduction and ALK Basics
  2. Guided demonstration of NSCLC cases with known clinical
  3. interpretation
  4. Guided demonstration of NSCLC cases with unknown clinical
  5. interpretation
  6. Practice session of NSCLC cases with unknown clinical interpretation
  7. Proficiency Test
VENTANA ALK (D5F3) CDx Assay
VENTANA HER2 Dual ISH breast cancer stain
HER2 Dual ISH Interpretation Training

This course was designed for pathologists and provides a step-by-step guide on the evaluation and scoring of HER2 Dual ISH staining. Participants are required to proceed through the five-part training program in chronological order.

Modules

  1. Basics and interpretation
  2. Guided demonstration of cases
  3. Practices cases with assisted interpretation
  4. Stain interpretation practice exam
  5. Stain interpretation exam
PD-L1 interpretation training series

Stay at the forefront of predictive diagnostics and make a positive impact on patient care. This a series of focused, interactive courses was developed to aid the scoring and interpretation of VENTANA PD-L1 (SP142) Assay* and VENTANA PD-L1 (SP263) Assay* to target those patients who are more likely to respond to specific therapies.

 

*CE IVD only. Not for use in diagnostic procedures in the US.

 

Modules:

 

  1. PD-L1 Basics Module: This course gives a background in the biology of PD-L1 and a description of the PD-L1 Assays.
  2. PD-L1 (SP142) UC Training: This course consists of five modules that go through the basics to interpret bladder tissue stained with the VENTANA PD-L1 (SP142) Assay, including an interactive assessment test to measure your own interpretation skills.
  3. PD-L1 (SP142) NSCLC Training: This course consists of four modules that go through the basics to interpret lung tissue stained with the VENTANA PD-L1 (SP142) Assay, including an interactive assessment test to measure your own interpretation skills.
  4. PD-L1 (SP142) TNBC Training: This course consists of five modules that go through the basics to interpret breast tissue stained with the VENTANA PD-L1 (SP142) Assay, including an interactive assessment test to measure your own interpretation skills.
  5. PD-L1 (SP263) UC Training: This course consists of nine modules that go through the basics to interpret bladder tissue stained with the VENTANA PD-L1 (SP263) Assay, including an interactive assessment test to measure your own interpretation skills.
  6. PD-L1 (SP263) NSCLC Training: This course consists of six modules that go through the basics to interpret lung tissue stained with the VENTANA PD-L1 (SP263) Assay, including an interactive assessment test to measure your own interpretation skills.
VENTANA SP142 assay therapy and slide image

Pathologist eLearning course curricula

Roche IHC lung cancer portfolio

Lung cancer courses

Learn more
Roche breast cancer IHC Assay panel patient image

Breast cancer courses

Learn more
Roche breast cancer IHC Assay panel patient image

Breast PD-L1 courses

Learn more
Roche cervical cancer cytology portfolio

Cervical cancer courses

Learn more
Roche Prostate IHC panel in eLabDoc

Urothelial cancer courses

Learn more
Roche hematopathology cancer IHC panel in eLabDoc

Other cancer types

Learn more
Roche Ventana Digital Pathology eLearning courses

Digital pathology courses

Learn more
DIASights webinar series

BrightTALK DIASights channel

 

This series—brought to you by Roche Diagnostics—features key opinion leaders' insights and curated educational content related to personalized diagnostics. We aim to ensure on ongoing conversation is taking place in this evolving area of healthcare.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche DIASights NTRK webinar
NTRK gene fusions in solid tumors: IHC and molecular testing strategies
Caterina Marchiò, MD, PhD and Reinhard Büttner, MD

 

May 12 2021 | 60 mins

 

In this webinar Drs. Marchiò and Büttner will review the role of NTRK gene fusions in solid tumors, with an in-depth look at IHC and molecular methods of testing. Dr. Marchiò will discuss some specific IHC staining examples and how to interpret them; while Dr. Büttner will provide insight on molecular testing considerations with strengths and weaknesses. This webinar will provide an expert look into the NTRK testing landscape with an opportunity for questions and discussion.

eLabDoc - search document databases and product catalogs for healthcare providers and researchers

Product information search in catalog for HCP's thumbnail
IVD product information

Full product catalog including links to third party Cell Marque document library.

 

Search product catalog for healthcare providers in eLabDoc

Please note that not all services and/or products are offered in all countries. For further details or for assistance in creating a Roche DiaLog account to access our eServices contact your local affiliate.

IHC/ISH assay portfolios by cancer type in eLabDoc

Roche breast cancer IHC Assay panel patient image

Breast cancer IHC portfolio

View in eLabDoc
Roche cervical cancer cytology portfolio

Cervical cancer portfolio

View in eLabDoc
Roche IHC lung cancer portfolio

Lung cancer IHC portfolio

View in eLabDoc
Roche colorectal cancer IHC portfolio in eLabDoc

Colorectal cancer IHC portfolio

View in eLabDoc
Roche hematopathology cancer IHC panel in eLabDoc

Hematopathology IHC portfolio

View in eLabDoc
Roche Prostate IHC panel in eLabDoc

Prostate cancer

View in eLabDoc
Roche  dermatopathology IHC portfolio in eLabDoc

Dermatopathology cancer IHC portfolio

View in eLabDoc